Atlas Trials

A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive Disorder

Clinical trial NCT03672175 · COMPLETED

Trial details

NCT number
NCT03672175
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2018-11-19
Primary completion
2019-09-24
Enrollment
581

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.